|
|
|
| FACULTY |
|
|
|
Dr.R.Douglas Shytle,Assistant Professor |
|
|
|
|
| Research
|
|
Dr.Shytle's interests involve both basic and clinical neuropsychopharmacology into various disorders of the brain. His focused research has been with Tourette's syndrome and the therapeutic potential of nicotinic receptor ligands for various neuropsychiatric disorders. More recent interest include the role of nutrition in slowing neurodegernative processes.
>>top
|
|
| Recent Publications |
|
Shytle RD, Mori T, Ehrart J, Zeng J, Shen N, Silver AA, Sanberg PR, and Tan J , Cholinergic Modulation of Microglial Activation Via alpha7 Nicotinic Receptors. Journal of Neurochemistry. 89:337-343, 2004.
Shytle RD, Sheehan DV, Newman MB, Wilkinson BJ, Sheehan, KH, Sanberg PR,Silver AA , The Tourette's Disorder Scale (TODS): Development, Reliability, and Validity. Assessment. 10(3):273-87, 2003.
Shytle RD, Silver AA, Lukas RJ, Newman MB, Sheehan DV, and Sanberg PR ,Nicotinic Acetylcholine Receptors as Targets for Antidepressants, Molecular Psychiatry 7:525-535, 2002.
Shytle RD, Silver AA, Wilkinson BJ, Sanberg, PR, A Pilot Controlled Trial of Transdermal Nicotine in the Treatment of Attention Deficit Hyperactivity Disorder. World Journal of Biological Psychiatry 3:150-155, 2002.
Shytle RD, Silver AA, Sheehan KH, Sheehan DV, and Sanberg PR, Neuronal Nicotinic Receptor Inhibition for Treating Mood Disorders: Preliminary Controlled Evidence with Mecamylamine, Depression and Anxiety 2002;16(3):89-92, 2002.
>>top |
|
| |
|
|
